• Policy
• Zemimet’s price drops 9.7% in 5 years…discounted 5 times
• by Lee, Tak-Sun Aug 30, 2022 05:54am

• Policy
• Kyowa Hakogirtin Postelligeo 20mg is expected to be approved
• by Lee, Hye-Kyung Aug 30, 2022 05:54am

• Company
• Piqray can be prescribed in 18 hospitals
• by Eo, Yun-Ho Aug 30, 2022 05:54am

• Company
• HIV tx Delstrigo is available in major national hospitals
• by Eo, Yun-Ho Aug 29, 2022 06:03am

• Company
• Pfizer Korea receives tax audit...files tax appeal
• by Aug 29, 2022 06:03am

• Policy
• "Raise the prescription rate for high-risk patients to 50%"
• by Lee, Jeong-Hwan Aug 29, 2022 06:03am

• Company
• South Korea is looking forward to Xpovio's benefit
• by Aug 29, 2022 06:02am

• Company
• NPU condemns the unilateral ERP of multinational companies
• by Aug 29, 2022 06:02am

• Company
• HK inno.N, Daewoong, & Jeil are competing to secure K-Cab
• by Kim, Jin-Gu Aug 29, 2022 06:02am

• Policy
• NHI turns to deficit with a mere 2.6% coverage improvement
• by Lee, Jeong-Hwan Aug 26, 2022 05:35am